[go: up one dir, main page]

HN1998000073A - Derivados de la 9 - oxima eritromicina - Google Patents

Derivados de la 9 - oxima eritromicina

Info

Publication number
HN1998000073A
HN1998000073A HN1998000073A HN1998000073A HN1998000073A HN 1998000073 A HN1998000073 A HN 1998000073A HN 1998000073 A HN1998000073 A HN 1998000073A HN 1998000073 A HN1998000073 A HN 1998000073A HN 1998000073 A HN1998000073 A HN 1998000073A
Authority
HN
Honduras
Prior art keywords
compounds
derivatives
oxima
erythromycin
well
Prior art date
Application number
HN1998000073A
Other languages
English (en)
Spanish (es)
Inventor
Yong Jin Wu
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of HN1998000073A publication Critical patent/HN1998000073A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
HN1998000073A 1997-06-11 1998-05-19 Derivados de la 9 - oxima eritromicina HN1998000073A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4934997P 1997-06-11 1997-06-11

Publications (1)

Publication Number Publication Date
HN1998000073A true HN1998000073A (es) 1999-01-08

Family

ID=21959341

Family Applications (1)

Application Number Title Priority Date Filing Date
HN1998000073A HN1998000073A (es) 1997-06-11 1998-05-19 Derivados de la 9 - oxima eritromicina

Country Status (31)

Country Link
EP (1) EP0988308A1 (fr)
JP (1) JP2000513026A (fr)
KR (1) KR20010013660A (fr)
CN (1) CN1259135A (fr)
AP (1) AP9801253A0 (fr)
AR (1) AR012244A1 (fr)
AU (1) AU7226798A (fr)
BG (1) BG103947A (fr)
BR (1) BR9810021A (fr)
CA (1) CA2293335A1 (fr)
CO (1) CO4940506A1 (fr)
CZ (1) CZ9904388A3 (fr)
EA (1) EA199901016A1 (fr)
GT (1) GT199800074A (fr)
HN (1) HN1998000073A (fr)
HR (1) HRP980316A2 (fr)
HU (1) HUP0002252A3 (fr)
ID (1) ID24529A (fr)
IL (1) IL132767A0 (fr)
IS (1) IS5251A (fr)
MA (1) MA26505A1 (fr)
NO (1) NO996108L (fr)
OA (1) OA11225A (fr)
PA (1) PA8451801A1 (fr)
PE (1) PE79899A1 (fr)
PL (1) PL337606A1 (fr)
TN (1) TNSN98083A1 (fr)
TR (1) TR199902995T2 (fr)
TW (1) TW448174B (fr)
WO (1) WO1998056800A1 (fr)
ZA (1) ZA985018B (fr)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN1998000159A (es) * 1997-10-29 1999-02-09 Monsanto Co Derivados de 9- amino - 3 ceto eritromicina
ES2243066T3 (es) * 1998-09-22 2005-11-16 Pfizer Products Inc. Antibioticos de carbamato y carbazato cetolida.
FR2786188B1 (fr) * 1998-11-24 2002-10-31 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur applicaion comme medicaments
US6258785B1 (en) 1998-12-02 2001-07-10 Pfizer Inc. Crystalline 9-E-(O-methyl)oxime of 11, 12-dideoxy-3-de(2,6-dideoxy-3-C-methyl-3-O-methyl-α-L-ribohexopyranosyloxy)-6-O-methyl-12,11-(iminocarbonyl-(2-(3-(4-(3-pyridinyl)1H-imadazol-1-yl)propyl)hydrazono))-3-oxoerythromycin
EP1298138B1 (fr) * 1998-12-10 2006-11-02 Pfizer Products Inc. Dérivés anitiobiotiques de Carbamate et de Carbazate Kètolides
US6284732B1 (en) * 1998-12-18 2001-09-04 Bio-Rad Laboratories, Inc. Peptides and peptide analogues designed from HFE protein and their uses in the treatment of iron overload diseases
ATE340183T1 (de) * 1999-04-16 2006-10-15 Kosan Biosciences Inc Antiinfektiöse makrolidderivate
HK1045523A1 (zh) 1999-05-24 2002-11-29 辉瑞产品公司 13-甲基红霉素衍生物
DK1181300T3 (da) * 1999-06-07 2004-01-26 Abbott Lab 6-O-carbamatketolidderivater
ID27331A (id) * 1999-09-29 2001-03-29 Pfizer Prod Inc Pembuatan antibiotik-antibiotik ketolida karbamat
EP1114826A3 (fr) * 1999-12-29 2001-10-31 Pfizer Products Inc. Macrolides antibactériennes et prokinétiques
EP1439186A3 (fr) * 1999-12-29 2004-11-03 Pfizer Products Inc. Intermédiaires pour macrolides antibactérielles et procinétiques
US6946446B2 (en) 2000-02-24 2005-09-20 Abbott Laboratories Anti-infective agents useful against multidrug-resistant strains of bacteria
US6403776B1 (en) 2000-07-05 2002-06-11 Pfizer Inc. Synthesis of carbamate ketolide antibiotics
WO2003090761A1 (fr) * 2002-04-25 2003-11-06 Abbott Laboratories Antibacteriens 9-oxime macrolide
US7091196B2 (en) 2002-09-26 2006-08-15 Rib-X Pharmaceuticals, Inc. Bifunctional heterocyclic compounds and methods of making and using same
EP1638549A4 (fr) * 2003-03-10 2011-06-15 Optimer Pharmaceuticals Inc Nouveaux agents antibacteriens
EP1723159B1 (fr) 2004-02-27 2019-06-12 Melinta Therapeutics, Inc. Composes macrocycliques et leurs procedes de fabrication et d'utilisation
US9453042B2 (en) 2007-10-25 2016-09-27 Cempra Pharmaceuticals, Inc. Process for the preparation of macrolide antibacterial agents
HRP20160222T1 (hr) 2008-10-24 2016-04-08 Cempra Pharmaceuticals, Inc. Biozaštite uporabom makrolida koji sadrže triazol
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
EP2475253B1 (fr) 2009-09-10 2016-10-26 Cempra Pharmaceuticals, Inc. Méthodes de traitement du paludisme, de la tuberculose et des maladies à complexe mycobacterium avium (mac)
CN102146085B (zh) * 2010-02-09 2014-03-26 北京理工大学 一种9-肟醚酮内酯衍生物、制备方法及其药物组合物
JP5711352B2 (ja) 2010-03-22 2015-04-30 センプラ ファーマシューティカルズ,インコーポレイテッド マクロライドの結晶形、およびその使用
CN102917708B (zh) 2010-05-20 2015-11-25 森普拉制药公司 制备大环内酯和酮内酯及其中间体的方法
US9815863B2 (en) 2010-09-10 2017-11-14 Cempra Pharmaceuticals, Inc. Hydrogen bond forming fluoro ketolides for treating diseases
IN2014DN08939A (fr) 2012-03-27 2015-05-22 Cempra Pharmaceuticals Inc
CA2905975A1 (fr) 2013-03-14 2014-09-25 Cempra Pharmaceuticals, Inc. Procedes pour traiter des maladies respiratoires et formulations pour la mise en oeuvre de ceux-ci
EP2968384A4 (fr) 2013-03-15 2017-02-15 Cempra Pharmaceuticals, Inc. Procédés convergents de préparation d'agents antibactériens macrolides

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL114589A (en) * 1990-11-21 1999-12-22 Roussel Uclaf Intermediates for the preparation of erythromycin derivatives
US5527780A (en) * 1992-11-05 1996-06-18 Roussel Uclaf Erythromycin derivatives
FR2718450B1 (fr) * 1994-04-08 1997-01-10 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.

Also Published As

Publication number Publication date
HRP980316A2 (en) 1999-04-30
NO996108D0 (no) 1999-12-10
IL132767A0 (en) 2001-03-19
NO996108L (no) 2000-02-10
TR199902995T2 (xx) 2000-02-21
KR20010013660A (ko) 2001-02-26
CZ9904388A3 (cs) 2002-10-16
HUP0002252A2 (hu) 2000-12-28
WO1998056800A1 (fr) 1998-12-17
ID24529A (id) 2000-07-20
CA2293335A1 (fr) 1998-12-17
AP9801253A0 (en) 1999-12-04
JP2000513026A (ja) 2000-10-03
BR9810021A (pt) 2000-09-19
CN1259135A (zh) 2000-07-05
IS5251A (is) 1999-11-16
TNSN98083A1 (fr) 2005-03-15
MA26505A1 (fr) 2004-12-20
CO4940506A1 (es) 2000-07-24
BG103947A (en) 2000-07-31
PA8451801A1 (es) 2000-05-24
EA199901016A1 (ru) 2000-06-26
ZA985018B (en) 1999-12-10
PE79899A1 (es) 1999-08-25
GT199800074A (es) 1999-11-27
TW448174B (en) 2001-08-01
PL337606A1 (en) 2000-08-28
EP0988308A1 (fr) 2000-03-29
HUP0002252A3 (en) 2002-01-28
AU7226798A (en) 1998-12-30
OA11225A (en) 2003-07-17
AR012244A1 (es) 2000-09-27

Similar Documents

Publication Publication Date Title
HN1998000073A (es) Derivados de la 9 - oxima eritromicina
GT199800075A (es) Derivados de macrolidos c-4" sustituidos.
ATE311209T1 (de) Kombinationen von antiseptischen und antibiotischen mitteln enthaltende medizinische vorrichtungen
GT199800163A (es) Derivados de 9-amino-3-ceto eritromicina.
GT199900093A (es) Trifluorometilpirrolcarboxamidas.
GT199700124A (es) Derivados de aminas biciclicas
ES2173876T3 (es) Nuevas 7-(sustituido)-8-(sustituido)-9-(amino sustituido)-6-desmetil-desoxitetraciclinas como agentes antibioticos.
ES2053763T3 (es) Composiciones estabilizadas de isotiazolonas.
ES2054867T3 (es) Plaguicidas y pesticidas.
BR9407711A (pt) Composto de ciclopeptídeo processo para preparaçao de um composto de ciclopeptídeo e parasiticida
PA8462201A1 (es) Compuestos de benceno sustituidos, procedimientos para su preparacion, y composiciones herbicidas y defoliantes que los contienen
GT199900192A (es) Nuevos antibioticos macrolidos.
ES2052463T1 (es) Antihipercolesterolemicos.
GT199800162A (es) Derivados de eritromicina triciclicos.
ES2055808T3 (es) Agente para la proteccion de plantas contra enfermedades.
AR027688A1 (es) Acilsulfimidas heterociclicas, procedimiento para su preparacion, agentes que las contienen y su empleo como agentes para combatir animales perjudiciales
GT199700104AA (es) Procedimientos e intermedios para preparar derivados de cromanol sustituidos
ES2144154T3 (es) Derivados de eritromicina a 9-0-oxima dotados de actividad antibiotica.
ATE242970T1 (de) Photoempfindliche zusammensetzung
ES2061811T3 (es) Uso de compuestos de gamma-oxibutenolido conjugados para tratar ulcera.
ATE100106T1 (de) Antiparasitisches mittel.
BR8504387A (pt) Processo para preparacao de derivados de sacarina acilados,composicoes pesticidas e processos para o combate a pragas e para a preparacao de composicoes
ATE300532T1 (de) Piperazinon-derivate
ES2101894T3 (es) Termoestabilizacion de policarbonatos aromaticos.
GT199900074A (es) 3-ceto derivados tricìclicos de 6-0metileritromicina.-